SCHEMBL5809244

SCHEMBL5809244

C/C(=N\NC(=O)c1cc(C)nc2ccccc12)c1ccccc1O

nearest known ligand 0.69

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.69
LMNA P02545 5/20 0.67
MEN1 O00255 4/20 0.67
KMT2A Q03164 4/20 0.67
RAB9A P51151 4/20 0.67
SMN1; SMN2 Q16637 3/20 0.67
NPC1 O15118 3/20 0.67
HTT P42858 2/20 0.67
POLB P06746 1/20 0.67
THRB P10828 1/20 0.67
MAPT P10636 2/20 0.64
GAA P10253 2/20 0.64
ALDH1A1 P00352 3/20 0.62
KDM1A O60341 1/20 0.53
HPGD P15428 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809250 1.00 L3MBTL1 (0.69) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL5809461 0.88 GAA (0.56) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL5814385 0.88 GAA (0.56) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL5813671 0.88 GAA (0.58) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL5813681 0.88 GAA (0.58) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL5809423 0.87 L3MBTL1 (0.65) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL5809437 0.87 L3MBTL1 (0.65) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL18292418 0.81 L3MBTL1 (1.00) L3MBTL1LMNAMEN1KMT2ARAB9A
SCHEMBL23701490 0.79 KDM1A (0.74) LMNAMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL684855 0.79 KDM1A (0.74) LMNAMEN1KMT2ARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed